Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status

Open Access

Peer-reviewed

Research Article

Jon Lidfeldt,

Affiliation Department of Clinical Sciences, Section of Oncology and Pathology, Lund University, Lund, Sweden
⨯
Pär-Ola Bendahl,

Affiliation Department of Clinical Sciences, Section of Oncology and Pathology, Lund University, Lund, Sweden
⨯
Carina Forsare,

Affiliation Department of Clinical Sciences, Section of Oncology and Pathology, Lund University, Lund, Sweden
⨯
Per Malmström,

Affiliations Department of Clinical Sciences, Section of Oncology and Pathology, Lund University, Lund, Sweden, Department of Oncology, Skåne University Hospital, Lund, Sweden
⨯
Mårten Fernö,

Affiliation Department of Clinical Sciences, Section of Oncology and Pathology, Lund University, Lund, Sweden
⨯
Mattias Belting

* E-mail: mattias.belting@med.lu.se

Affiliations Department of Clinical Sciences, Section of Oncology and Pathology, Lund University, Lund, Sweden, Department of Oncology, Skåne University Hospital, Lund, Sweden
⨯

Reader Comments (0)

Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Prognosis
Is the Subject Area "Prognosis" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Histology
Is the Subject Area "Histology" applicable to this article?

Thanks for your feedback.
Breast tumors
Is the Subject Area "Breast tumors" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.